| Name | Title | Contact Details |
|---|
Residence XII is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Behavioral Dimensions Inc is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nature`s Way® is one of the most recognized and trusted manufacturers of dietary supplements and vitamins. A pioneer in herbal supplements, the Nature`s Way brand is known for its expansive offerings of whole herbs, standardized extracts, vitamins & minerals, and homeopathic remedies. Beyond herbal supplements, Nature`s Way manufactures trusted brands such as Alive! ® multi-vitamins, Fortify probiotics, Umcka® Cold Care, and Sambucus. Our brands are sold through retail partners in the grocery, drug, mass, health food store, eCommerce and other channels, and we are proud to be growing rapidly. Employees at Nature`s Way have a passion for building trustworthy brands that help improve the health and wellness of others. This is our mission and it forms the basis of everything we do. Whether developing science-based formulas, utilizing top-quality ingredients, or diligently adhering to Good Manufacturing Practices (GMP), Nature`s Way is known for its unwavering commitment to quality and efficacy. That`s why consumers know that if it`s Nature`s Way, they can Trust the Leaf®.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Osceola Regional Medical Center is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.